Abstract

An effective and timely prevention of diseases in animal companions is a major task faced by the modern veterinary science. This research featured the correlation between malignant neoplasms and ophthalmological diseases in cats. The authors studied the multifactorial effect on the neoplastic proliferation and cancer-related ophthalmopathy to develop a general scheme of neoplastic proliferation in cats.
The effect of exogenous and endogenous factors on neoplastic proliferation was described based on experimental studies of numerous samples taken from 192 cats, including 67 cancer patients. The comprehensive methodological approach included anamnestic data sampling, clinical examination, examination of the pathological area, hematology, cytomorphology, and chemical-toxicological tests.
The cats with various ophthalmopathies were simultaneously diagnosed with one or more of the following cancer types: carcinoma (37.13%), squamous cell carcinoma (32.83%), lymphoma (29.85%), sarcoma (20.89%), melanoma (2.98%), and mastocytoma (1.49%).
The main factors of neoplastic proliferation included diet, care, living conditions, physical activity, stress, chronic inflammation, repeated cases, the rate of increase/decrease in clinical signs, previous therapies, etc. In most cases, the cancer-related ophthalmopathy developed as a result of tumor metabolites or as a side-effect of chemotherapy. The incidence of cancer-related ophthalmopathy increased with age.
Cancer was found to correlate with the amounts of zinc, iron, and lead in the fur. Another correlation occurred between carcinomas, especially mammary tumors, and the high copper content in the fur.

FUNDING

The research was part of Project no. FSMF-2022-0003 supported by the Ministry of Higher Education and Science of the Russian Federation: Etiopathogenesis and development of methods for diagnosis, prevention, and treatment of immunemediated paraneoplastic ophthalmopathy in animals. It was conducted on the premises of the Research Laboratory of Ophthalmology, Oncology, and Animal Biochemistry, Russian Biotechnological University (ROSBIOTECH), Moscow, Russia.

REFERENCES

1. Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, et al. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Proliferation. 2020;53(8):e12865. https://doi.org/10.1111/cpr.12865
2. Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling. 2020;18:59. https://doi.org/10.1186/s12964-020-0530-4
3. Stepanova MV, Sotnikova LF, Zaitsev SYu. Relationships between the content of micro- and macroelements in animal samples and diseases of different etiologies. Animals. 2023;13(5):852. https://doi.org/10.3390/ani13050852
4. Ludwig L, Dobromylskyj M, Wood GA, van der Weyden L. Feline oncogenomics: What do we know about the genetics of cancer in domestic cats? Veterinary Sciences. 2022;9(10):547. https://doi.org/10.3390/vetsci9100547
5. Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, et al. The National Cancer Institute-American society of Clinical Oncology Cancer Trial accrual symposium: Summary and recommendations. Journal of Oncology Practice. 2013;9(6):267–276. https://doi.org/10.1200/JOP.2013.001119
6. Rolph KE, Cavanaugh RP. Infectious causes of neoplasia in the domestic cat. Veterinary Sciences. 2022;9(9):467. https://doi.org/10.3390/vetsci9090467
7. Shishin MV, Prosekov AYu. Investigation of morphological and antimicrobial properties of intestinal tract microorganisms. Food Processing: Techniques and Technology. 2015;39(4):134−137. (In Russ.)
8. Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, et al. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 2021;13(9):2025. https://doi.org/10.3390/cancers13092025
9. Pham AT, van Dijk BAC, van der Valk ES, van der Vegt B, van Rossum EFC, et al. Chronic stress related to cancer incidence, including the role of metabolic syndrome components. Cancers. 2024;16(11):2044. https://doi.org/10.3390/cancers16112044
10. Dutta Majumder P, Marchese A, Pichi F, Garg I, Agarwal A. An update on autoimmune retinopathy. Indian Journal of Ophthalmology. 2020;68(9):1829–1837. https://doi.org/10.4103/ijo.IJO_786_20
11. Henry K. Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment. Seminars in Diagnostic Pathology. 2019;36(4):204–210. https://doi.org/10.1053/j.semdp.2019.01.002
12. Naramala S, Ahmad J, Adapa S, Gavini F, Konala VM. Case series of cancer-associated retinopathy (CAR). Cureus. 2019;11(6):e4872. https://doi.org/10.7759/cureus.4872
13. Uemura A, Fruttiger M, d'Amore PA, de Falco S, Joussen AM, et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Progress in Retinal and Eye Research. 2021;84:100954 https://doi.org/10.1016/j.preteyeres.2021.100954
14. Thomas AS. Paraneoplastic retinopathies: An update on pathogenesis, diagnosis and management. Annals of Eye Science. 2024;9:2. https://doi.org/10.21037/aes-23-14
15. Maeda A, Maeda T, Liang Y, Yenerel M, Saperstein DA. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen. Molecular vision. 2006;12:885–891.
16. Serrano NC, Millan P, Páez M-C. Non-HLA associations with autoimmune diseases. Autoimmunity Reviews. 2006;5(3):209–214. https://doi.org/10.1016/j.autrev.2005.06.009
17. Liu P, Wang S, Zhang C, Li Y. Paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian dysgerminoma: A case report and literature review. Frontiers in Immunology. 2024;15:1424243. https://doi.org/10.3389/fimmu.2024.1424243
18. Maiorca C, Moret F, Martines V, Tramontano D, Papassifachis MA, et al. Paraneoplastic neuromyelitis optica spectrum disorder associated with lung adenocarcinoma: A case report. Frontiers in Immunology. 2022;8:743798. https://doi.org/10.3389/fmed.2021.743798
19. Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, et al. Collapsin response-mediator protein 5-associated retinitis, vitritis, and optic disc edema. Ophthalmology. 2020;127(2):221–229. https://doi.org/10.1016/j.ophtha.2019.09.012
20. Garibaldi M, Calabrò F, Merlonghi G, Pugliese S, Ceccanti M, et al. Immune checkpoint inhibitors (ICIs)-related ocular myositis. Neuromuscular Disorders. 2020;30(5):420–423. https://doi.org/10.1016/j.nmd.2020.02.013
21. Gordon L, Dinkin M. Paraneoplastic syndromes in neuro-ophthalmology. Continuum. 2019;25(5):1401–1421. https://doi.org/10.1212/CON.0000000000000788
22. Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nature Reviews Clinical Oncology. 2019;16(9):535–548. https://doi.org/10.1038/s41571-019-0194-4
23. Becquart O, Lacotte J, Malissart P, Nadal J, Lesage C, et al. Myasthenia gravis induced by immune checkpoint inhibitors. Journal of Immunotherapy. 2019;42(8):309–312. https://doi.org/10.1097/CJI.0000000000000278
24. Dyulger GP, Dyulger PG, Alikhanov O, Sedletskaya ES, Latynina ES, et al. Epidemiology, risk factors and pathomorphological features of mammary tumors in cats. Bulletin of the National academy of sciences of the Republic of Kazakhstan. 2020;(6):78–84. https://doi.org/10.32014/2020.2518-1467.185
25. Govoni VM, da Silva TC, Guerra JM, Pereira IVA, Queiroga FL, et al. Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma. Veterinary and Comparative Oncology. 2021;19(2):404–408. https://doi.org/10.1111/vco.12685
26. Nosalova N, Huniadi M, Ľubica H, Valenčáková A, Horňák S, et al. Canine mammary tumors: Classification, biomarkers, traditional and personalized therapies. International Journal of Molecular Sciences. 2024;25(5):2891. https://doi.org/10.3390/ijms25052891
27. Zhu Z, Kitano T, Morimatsu M, Ochiai K, Ishiguro-Oonuma T, et al. A highly conserved region in BRCA2 suppresses the RAD51-interaction activity of BRC repeats. Veterinary Sciences. 2023;10(2):145. https://doi.org/10.3390/vetsci10020145
28. Granados-Soler J-L, Taher L, Beck J, Bornemann-Kolatzki K, Brenig B, et al. Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways. Scientific Reports. 2022;12:17025. https://doi.org/10.1038/s41598-022-20874-5
29. Oh JH, Cho J-Y. Comparative oncology: Overcoming human cancer through companion animal studies. Experimental & Molecular Medicine. 2023;55(4):725–734. https://doi.org/10.1038/s12276-023-00977-3
30. Naito E, Yuki M, Hirano T, Kainuma D, Aoyama R. Prognostic utility of preoperative neutrophil-lymphocyte ratio in cats with malignant mammary tumors. Research in Veterinary Science. 2021;135:349–354. https://doi.org/10.1016/j.rvsc.2020.10.015
31. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Gastroenterology Review. 2019;14(2):89–103. https://doi.org/10.5114/pg.2018.81072
32. Goodarzi E, Beiranvand R, Naemi H, Momenabadi V, Khazaei Z. Worldwide incidence and mortality of colorectal cancer and human development index (HDI): An ecological study. World Cancer Research Journal. 2019;6:e1433. https://doi.org/10.32113/wcrj_201911_1433
33. Peterse EFP, Meester RGS, Siegel RL, Chen JC, Dwyer A, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018;124(14):2964–2973. https://doi.org/10.1002/cncr.31543
34. Zhang S, Xiao X, Yi Y, Wang X, Zhu L, et al. Tumor initiation and early tumorigenesis: Molecular mechanisms and interventional targets. Signal Transduction and Targeted Therapy. 2024;9:149. https://doi.org/10.1038/s41392-024-01848-7
35. Capriotti G, Piccardo A, Giovannelli E, Signore A. Targeting copper in cancer imaging and therapy: A new theragnostic agent. Journal of Clinical Medicine. 2022;12(1):223. https://doi.org/10.3390/jcm12010223
36. Lener MR, Scott RJ, Wiechowska-Kozłowska A, Serrano-Fernández P, Baszuk P, et al. Serum concentrations of selenium and copper in patients diagnosed with pancreatic cancer. Cancer Research and Treatment: Official Journal of Korean Cancer Association. 2016;48(3):1056–1064. https://doi.org/10.4143/crt.2015.282
37. Wittung-Stafshede P. A copper story: From protein folding and metal transport to cancer. Israel Journal of Chemistry. 2016;56(9–10):671–681. https://doi.org/10.1002/ijch.201600019
38. Golovin TS, Tolkachev VA, Everstova EA, Vanina NV. Clinic – laborantorny indicators status of cancer patients of cats. Bulletin of the Kursk State Agricultural Academy. 2017;(1):28–30. (In Russ.)
39. Mitrokhina NV. Methods of Laboratory Diagnostics. Moscow: Veterinarnyj centr patomorfologii i laboratornoj diagnostiki doktora N.V. Mitrokhinoj; 2022. 89 p.
40. Pinello K, Amorim I, Pires I, Canadas-Sousa A, Catarino J, et al. Vet-OncoNet: Malignancy analysis of neoplasms in dogs and cats. Veterinary Sciences. 2022;9(10):535. https://doi.org/10.3390/vetsci9100535
41. Pérez-Enriquez JM, Romero-Romero L, Alonso-Morales RA, Fuentes-Pananá EM. Tumor prevalence in cats: Experience from a reference diagnostic center in Mexico City (2006–2018). Veterinaria México OA. 2020;7(4). https://doi.org/10.22201/fmvz.24486760e.2020.4.837
42. Pereira AM, Maia MRG, Fonseca AJM, Cabrita ARJ. Zinc in dog nutrition, health and disease: A review. Animals. 2021;11(4):978. https://doi.org/10.3390/ani11040978
43. Enginler SO, Toydemir TSF, Ates A, Ozturk B, Erdogan O, et al. Examination of oxidative /Antioxidative status and trace element levels in dogs with mammary tumors. Bulgarian Journal of Agricultural Science. 2015;21(5):1086–1091.
44. Harro CC, Smedley RC, Buchweitz JP, Langlois DK. Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma. Journal of Veterinary Internal Medicine. 2019;33(5):2193–2199. https://doi.org/10.1111/jvim.15619
45. Shahrokh M, Alsultan M, Kabalan Y. The relationship between papillary thyroid carcinoma and preoperative TSH level: A cross-sectional study from Syria. Medicine. 2023;102(28):e34283. https://doi.org/10.1097/MD.0000000000034283